Eli Lilly and Company: all 2,262 studies
Page 1 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY3839056 in Healthy ParticipantsNot yet recruitingNCT07945314Phase 1
- A Study of LY3945262 in Healthy ParticipantsNot yet recruitingNCT07943091Phase 1
- A Study of Tersolisib (LY4064809) and Abemaciclib With Hormone Therapies in Participants With PIK3CA-Mutated Early Breast CancerNot yet recruitingNCT07935317Phase 2
- A Study Assessing Eloralintide (LY3841136) in Healthy ParticipantsNot yet recruitingNCT07935304Phase 1
- A Study of LY4336619 in Adult Participants With Advanced Solid TumorsNot yet recruitingNCT07928258Phase 1
- A Study of Brenipatide in Participants With Major Depressive DisorderNot yet recruitingNCT07928245Phase 2
- A Study of LY3981314 in Participants With Autoimmune HepatitisNot yet recruitingNCT07928219Phase 1
- A Study of Tersolisib (LY4064809) in Participants With Kidney Impairment Compared With Participants With Normal Kidney FunctionNot yet recruitingNCT07924930Phase 1
- A Study of Bimagrumab in Participants With HFpEFNot yet recruitingNCT07920887Phase 2
- A Study of Imlunestrant (LY3484356) in Healthy Female ParticipantsNot yet recruitingNCT07918859Phase 1
- A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise HealthyRecruitingNCT07915245Phase 1
- A Study of Lepodisiran (LY3819469) in Participants With High Lipoprotein(a)RecruitingNCT07914738Phase 1
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskNot yet recruitingNCT07900633Phase 3
- A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 DiabetesNot yet recruitingNCT07890376Phase 2
- A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).Not yet recruitingNCT07883590Phase 1
- A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 DiabetesRecruitingNCT07881887Phase 1
- A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 DiabetesRecruitingNCT07881458Phase 3
- A Study of EloraTZP in Adult Participants With Obesity Without Type 2 DiabetesNot yet recruitingNCT07881432Phase 3
- A Study of Single and Multiple Doses of LY5625573 in Healthy Participants, Including Japanese and Chinese Populations, and Participants With Inflammation (High C-Reactive Protein)RecruitingNCT07867340Phase 1
- A Study of LY4515100 in Healthy Male ParticipantsRecruitingNCT07867327Phase 1
- A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)RecruitingNCT07843459Phase 1
- A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular DiseaseRecruitingNCT07839936Phase 2
- A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's DiseaseNot yet recruitingNCT07838155Phase 4
- A Study of Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial CancerNot yet recruitingNCT07827612Phase 2
- A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in IndiaNot yet recruitingNCT07822880Phase 4
- A Study of Abemaciclib (LY2835219) in Healthy ParticipantsRecruitingNCT07818967Phase 1
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)RecruitingNCT07817875Phase 3
- A Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C MutationNot yet recruitingNCT07814417Phase 2
- A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise HealthyRecruitingNCT07808073Phase 1
- A Study of Eloralintide (LY3841136) in Female Participants With Obesity or OverweightRecruitingNCT07808060Phase 1
- A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or ObesityRecruitingNCT07803744Phase 1
- A Study of LY5625575 in Healthy Participants and in Participants With Inflammation (Elevated C-Reactive Protein)RecruitingNCT07801300Phase 1
- A Study Comparing Two Ways of Taking Olomorasib (LY3537982) in Healthy ParticipantsRecruitingNCT07794592Phase 1
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityRecruitingNCT07794579Phase 3
- A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health ProblemsNot yet recruitingNCT07790861Phase 3
- A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's DiseaseRecruitingNCT07787182Phase 1
- A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's DiseaseRecruitingNCT07787169Phase 1
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventRecruitingNCT07783802Phase 2
- A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive DisorderRecruitingNCT07775300Phase 3
- A Study of LY4226695 in Healthy ParticipantsRecruitingNCT07767487Phase 1
- A Study of Macupatide (LY3532226) in Participants With Obesity or Overweight Without Type 2 DiabetesNot yet recruitingNCT07765511Phase 1
- A Study of LY4355756 in Healthy ParticipantsRecruitingNCT07765498Phase 1
- A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)RecruitingNCT07759245Phase 2
- A Study of LY4178256 in Healthy ParticipantsRecruitingNCT07698210Phase 1
- Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid TumorsAvailableNCT07675057
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesRecruitingNCT07668336Phase 3
- A Study of Eloralintide (LY3841136) in Participants With Overweight or ObesityRecruitingNCT07665879Phase 1
- A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise HealthyRecruitingNCT07654972Phase 1
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis PainRecruitingNCT07641517Phase 2
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back PainRecruitingNCT07641504Phase 2
- Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular DegenerationRecruitingNCT07630649Phase 2
- Pre-approval Expanded Access of Retatrutide (LY3437943)AvailableNCT07629401
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingRecruitingNCT07613307Phase 3
- A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High RiskRecruitingNCT07613294Phase 3
- A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved IndicationRecruitingNCT07612267Phase 4
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).RecruitingNCT07602582Phase 3
- A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of HypersomnolenceRecruitingNCT07598708Phase 2/3
- A Study of LY3439539 in Participants With Alzheimer's DiseaseRecruitingNCT07598370Phase 1
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or OverweightRecruitingNCT07589608Phase 2
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)RecruitingNCT07589595Phase 2
- A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)RecruitingNCT07571200Phase 1
- A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisRecruitingNCT07571174Phase 1
- Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's DiseaseRecruitingNCT07571161Phase 3
- A Study of LY4302814 in Healthy ParticipantsRecruitingNCT07566338Phase 1
- mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young AdultsRecruitingNCT07557602Phase 1
- A Study of LY3971297 in Participants With Heart FailureRecruitingNCT07547540Phase 1
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)RecruitingNCT07545772Phase 2
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)RecruitingNCT07545759Phase 2
- A Study of LY4005130 in Adult Participants With Non-Segmental VitiligoRecruitingNCT07533019Phase 2
- A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)RecruitingNCT07533006Phase 2
- A Study of LY4515100 in Participants With Pain Following Third Molar RemovalRecruitingNCT07511816Phase 2
- Long Term Follow-up Study of AAVAnc80-antiVEGF Gene TherapyEnrolling by invitationNCT07503613
- A Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's DiseaseNot yet recruitingNCT07485153
- A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's DiseaseRecruitingNCT07483099Phase 2
- A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseaseRecruitingNCT07483073Phase 2
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)RecruitingNCT07482176Phase 3
- A Study of Mirikizumab Solution (LY3074828) in Healthy ParticipantsRecruitingNCT07446101Phase 1
- A Study of ORN252 in Healthy ParticipantsRecruitingNCT07439796Phase 1
- A Study of Brenipatide in Participants With Opioid Use DisorderRecruitingNCT07420283Phase 2
- LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisRecruitingNCT07415044Phase 2
- A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 YearsRecruitingNCT07413666Phase 1
- A Study of Brenipatide in Adult Participants With Major Depressive DisorderRecruitingNCT07412756Phase 3
- A Study of Brenipatide in Adult Participants With SchizophreniaRecruitingNCT07410507Phase 2
- A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.RecruitingNCT07401862Phase 1
- A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruitingNCT07392190Phase 3
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or OverweightRecruitingNCT07369011Phase 3
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightRecruitingNCT07353931Phase 3
- A Study of LY4515100 in Healthy ParticipantsRecruitingNCT07339722Phase 1
- A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesRecruitingNCT07321886Phase 3
- NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' DiseaseRecruitingNCT07305818Phase 1
- A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast CancerRecruitingNCT07287098Phase 2
- A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)RecruitingNCT07286175Phase 2
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic PainRecruitingNCT07285018Phase 2
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesRecruitingNCT07282600Phase 3
- A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)RecruitingNCT07276958Phase 1
- A Study of Solbinsiran (LY3561774) in Participants With Severe HypertriglyceridemiaRecruitingNCT07269210Phase 2
- A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid ArthritisRecruitingNCT07258849Phase 1
- A Study of [18F]LY4214835 in Healthy Volunteers and Participants With CancerRecruitingNCT07258836Phase 1
- A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's DiseaseRecruitingNCT07254234
- A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)RecruitingNCT07247084Phase 4